Diabetic Nephropathy FAQ
Diabetic Nephropathy FAQ
This page answers only the practical questions — what to send, what happens here, when travelling should be postponed, what it costs and how it is paid for, and how care continues afterwards. Every clinical question is answered by the other six pages in this guide, and this page does not repeat them.
What it costs
The initial assessment is free: records sent ahead are reviewed without charge, and the written opinion — including whether assessment here would add anything to the care you already receive — comes back before any payment is discussed. That ordering is deliberate. A large share of the enquiries we receive are answered in that letter, and no travel follows.
Where treatment here is appropriate, complete care in China typically runs at 30–50% of comparable care in Europe or the United States, consistently across conditions and programmes. For diabetic kidney disease the components are the assessment and its investigations — urine studies, blood tests, imaging, an eye examination and, where an atypical feature is present, a kidney biopsy with immunofluorescence and electron microscopy — followed by the medicines prescribed and the follow-up measurements. An itemised quotation is provided once the records define what is actually needed, because a patient whose picture is typical needs far less than one in whom a second kidney disease is a live possibility. What this page will not do is give a price without that: the range depends entirely on which of those applies.
How long the visit takes
This is stated in the written plan before anything is booked, because it depends on what the assessment turns up rather than on a standard package. An assessment built around urine and blood testing, an eye examination and consultation is arranged as outpatient visits and can be completed in a short stay. Where the findings call for a kidney biopsy, an extra day of observation is built in — the procedure itself is short, and the monitoring afterwards is what takes the time.
Because most people travelling for this condition also have diabetes to manage, the plan states the expected total stay before booking, so that medicine supplies, glucose monitoring and flights are arranged against a number rather than an estimate. Families commonly add time either side for travel and a settling consultation.
Which records to send
Five groups of documents decide most of the assessment, and none requires translation beyond what our coordinators handle.
| What to send | What it answers |
|---|---|
| Urine albumin results with dates, ideally as a ratio | Whether albumin loss is present and persistent — two abnormal results out of three is what establishes it |
| Creatinine and filtration readings, ideally a series | Where you are and whether it is moving. Three readings over six months are worth more than one precise one |
| Urine microscopy, if it was ever done | Whether cells and casts are present, which is the clearest signal that this may not be diabetic at all |
| Any eye examination report | Whether retinopathy is present — in type 1 diabetes its absence changes the whole question |
| Blood pressure readings, including home ones | Whether the most treatable driver is controlled, and on how much medicine |
| Full medicines list, including over-the-counter and supplements | Whether something being taken regularly is stressing the kidney, and what can be substituted |
Add the date your diabetes was diagnosed and its type, your glucose readings if you keep them, and any biopsy report you already hold. Photographs of clinic letters are acceptable to start. Where the albumin has only ever been measured once, or always during an infection or an illness, the opinion says so and names the tests to arrange locally first.
When travelling is safe — and when it is not
Postpone travel with new swelling and reduced urine output, which suggests an acute injury on top of chronic disease; during any acute illness with vomiting or dehydration; in the days immediately after a kidney biopsy, until the post-procedure observation period is complete; and while blood pressure is severely uncontrolled. These are not administrative cautions — each is a state in which the assessment here would be distorted by the acute problem, or in which the flight itself carries real risk.
For everyone else, travelling with this condition is routine with a few disciplines. Carry medicines and glucose monitoring equipment in hand luggage, never in the hold, and carry more than the trip appears to need, split between two bags. Carry a doctor's letter covering the condition and the medicines — useful at a border and essential if you need care away from your own team. Carry glucose, drink water on a long flight and move regularly. And know what to stop during a febrile illness: that plan is written into the summary you take home, and it is worth reading before you need it.
Insurance and payment
We work with more than 30 commercial insurers on direct billing. Coordinators confirm coverage, exclusions and the paperwork required before arrival rather than after it — which matters here, because an assessment that turns out to need a biopsy costs rather more than one that does not, and the pre-authorisation should cover the possibility.
Patients without suitable coverage receive an itemised quotation and pay directly. Either way, costs are agreed in writing before travel, and the records review itself is free and happens first. Where an insurer requires a specific form or clinical letter, our department completes it as part of the assessment rather than as a billable extra.
What happens after you go home
You leave with a written summary in English covering the diagnosis and how it was established, the stage on both axes, the blood pressure and albumin targets that apply in your case, the medicines and what each is for, the monitoring intervals and a sick-day plan. Laboratory and pathology data are exported in standard formats, including the biopsy report where one was performed, so your local team continues the same series rather than starting a new one.
Follow-up continues with your own team, and our international department remains a written point of contact for questions about the opinion. Where a medicine was started here that needs monitoring — potassium after finerenone, or filtration after starting an SGLT2 inhibitor — the summary states what to check and when, so the first follow-up blood test at home is not a matter of guesswork. Where correspondence with your local doctor would help, we provide it in writing.
Coming with someone
A companion is welcome and often useful, particularly where the visit includes a procedure or a change of medicines. Their practical value is in the room: a second person hearing the same explanation, holding the questions that were written down and then forgotten, and managing the logistics of a day that includes fasting blood tests and a scan.
What we ask is that the companion be present for the consultation where a decision is being made — about a biopsy, or about starting a medicine that changes the monitoring — rather than only for travel. Coordinators arrange accommodation near the department and, where a companion is also the person managing your medicines at home, we make sure they leave with the same written summary you do.
Where nobody can travel with you, the assessment runs the same way, and the written summary is the safeguard: everything that would have been said to a companion is in it, including the sick-day plan and the date of the next review.